SecBot SecBot
Institutional Cluster

MRK

Merck & Co., Inc.
BEARISH
Impact 4/10
Horizonweeks Processed13d 13h ago
Institutional cluster: 3 buyers, 3 sellers (mixed)
Actionable Insight ▼ Bearish

The cluster shows active managers reducing Merck exposure after Q3 earnings that missed EPS consensus, despite a sales beat. The largest seller (Assenagon, -$119.2M) and the absence of insider buying suggest caution. Monitor the Q4 2026 10-K for revenue and EPS trajectory, particularly Keytruda growth sustainability and Winrevair ramp, as well as any further institutional selling in the next 13F cycle.

DirectionBearish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$144.67
T+0 close · Nov 3, 2026 · via day close
Latest settled
+2.34%
T+5 · $148.05
Vs SPY
+2.92%
α at T+5
Next horizon
T+20
in 15d
  1. T+0 · Nov 3 $144.67entry
  2. T+1 · 13d ago +3.93%α +2.28% · $150.36
  3. T+5 · 7d ago +2.34%α +2.92% · $148.05
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A mixed institutional cluster for Merck in Q3 2026 shows three small-to-mid-sized asset managers adding $44.7M in positions while three other managers trimmed $165.1M, for net selling of $120.4M. The cluster follows Q3 earnings reported 5 days ago that beat sales consensus but missed EPS estimates, with narrowed guidance including one-time charges. The selling is concentrated in larger positions (Assenagon alone cut $119.2M), while buying came from smaller funds, creating a net bearish signal from active managers.

Key Financial Metrics

Direction
distributing
Buy Value
$104.5M
Sell Value
$165.1M
Net Flow
-$120.4M

Institutional Positions

Net institutional flow: -$120.4M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Exchange Traded ConceptsADD+94%$32.0M$17.4M
Congress Asset ManagementDOUBLED+238.9%$2.6M$2.0M
Td Waterhouse CanadaADD+37%$69.9M$25.4M

▼ Sellers (3)

InstitutionActionChangePrev ValueValue Δ
Alps AdvisorsTRIM-43.7%$58.2M-$21.2M
Assenagon Asset ManagementTRIM-41.9%$347.3M-$119.2M
Fort Washington Investment AdvisorsTRIM-37.1%$85.7M-$24.8M

Key Facts

  • 3 institutional buyers added $44.7M in new holdings during Q3 2026
  • 3 institutional sellers trimmed $165.1M, led by Assenagon Asset Management cutting $119.2M
  • Net institutional selling of $120.4M in the quarter
  • Q3 2026 earnings (filed Oct 29): sales $18.1B (+5% YoY) beat $17.33B consensus, but GAAP EPS $2.04 missed $2.09 consensus
  • Full-year 2026 non-GAAP EPS guidance raised to $2.77-$2.82 but includes $0.12/share in one-time charges
  • No open-market insider buying during the quarter (confluence score 9/100, divergent)
  • All six funds are asset managers (active), not passive/index funds, strengthening the signal

Financial Impact

Net institutional selling of $120.4M (3 buyers added $44.7M, 3 sellers trimmed $165.1M) in Q3 2026

institutional ownershipnet capital flows

Risk Factors

  • 13F data is 45+ days stale; positions may have been unwound or reversed since quarter-end
  • Q3 GAAP EPS miss and one-time charges in guidance may weigh on near-term sentiment
  • Patent cliff for Keytruda (2028) remains a long-term overhang despite near-term growth
  • Selling by Assenagon ($119.2M) represents a large conviction reduction by a single manager

Market Snapshot

Price
$145.54
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
71% bullish (35 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-MRK-2026-Q3

Track record

34 reports on MRK

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +16.92% at T+20 after the Aug 6, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 12, 20264d ago 144 Neutral 2/10 Entry $147.76 settles Feb 11
  2. Nov 9, 20268d ago PTAB Trial Neutral 2/10 Entry $148.05 settles Feb 8
  3. Nov 3, 202613d ago 3 Neutral 2/10 Entry $144.67 settles Feb 1
  4. Nov 3, 202613d ago Institutional Cluster Bearish 4/10 Viewing Entry $144.67 settles Feb 1
  5. Nov 2, 202614d ago 144 Neutral 2/10 Entry $144.67 settles Feb 1
  6. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $146.33 settles Jan 27
  7. Oct 22, 202625d ago 3/A Neutral 1/10 Entry $145.27 settles Jan 21
  8. Oct 21, 202627d ago PTAB Trial Neutral 3/10 Entry $147.24 settles Jan 20
  9. Oct 15, 20264w ago PTAB Trial Bullish 6/10 Entry $145.95 settles Jan 13
  10. Oct 15, 20264w ago PTAB Trial Bullish 5/10 Entry $145.95 settles Jan 13
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (9h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026